Research graph
References from Statin use and 28-day survival in critically ill patients with non-acute myocardial infarction cardiogenic shock. Local targets link to admitted publications; unresolved targets remain external evidence.
Management of cardiogenic shock complicating myocardial infarction: an update 2019.
10.1093/eurheartj/ehz363 · 2019 · External reference
Management of cardiogenic shock: a narrative review.
10.1186/s13613-024-01260-y · 2024 · External reference
Management of cardiogenic shock: state-of-the-art.
10.1007/s00134-024-07618-x · 2024 · External reference
Cardiogenic shock after acute myocardial infarction: a review.
10.1001/jama.2021.18323 · 2021 · External reference
Clinical profile, short and long-term outcomes of non-ischaemic cardiogenic shock: a FRENSHOCK sub-analysis.
10.1002/ehf2.15046 · 2025 · External reference
Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association.
10.1161/cir.0000000000000525 · 2017 · External reference
The role of inflammation in the pathogenesis of cardiogenic shock secondary to acute myocardial infarction: a narrative review.
10.3390/biomedicines12092073 · 2024 · External reference
The lipid and non-lipid effects of statins.
10.1016/s0163-7258(03)00055-x · 2003 · External reference
Favourable effect of statin therapy on early survival benefit at the time of percutaneous coronary intervention for ST-elevation myocardial infarction and shock.
10.4244/eijv6i3a58 · 2010 · External reference
Statin therapy reduces the risk of ventricular arrhythmias, sudden cardiac death, and mortality in heart failure patients: a nationwide population-based cohort study.
10.1016/j.ijcard.2013.07.036 · 2013 · External reference
Effect of statins on ventricular tachyarrhythmia, cardiac arrest, and sudden cardiac death: a meta-analysis of published and unpublished evidence from randomized trials.
10.1093/eurheartj/ehs005 · 2012 · External reference
Patient characteristics, treatment and outcome in non-ischemic vs. ischemic cardiogenic shock.
10.3390/jcm9040931 · 2020 · External reference
Statins for the primary prevention of cardiovascular disease.
2013 · External reference
Immortal time bias in pharmaco-epidemiology.
10.1093/aje/kwm324 · 2008 · External reference
Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes.
10.1136/bmj.b5087 · 2010 · External reference
Landmark analysis at the 25-year landmark point.
10.1161/circoutcomes.110.957951 · 2011 · External reference
MIMIC-IV, a freely accessible electronic health record dataset.
10.1038/s41597-022-01899-x · 2023 · External reference
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.
10.1016/j.jclinepi.2007.11.008 · 2008 · External reference
Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples.
10.1002/sim.3697 · 2009 · External reference
Double-adjustment in propensity score matching analysis: choosing a threshold for considering residual imbalance.
10.1186/s12874-017-0338-0 · 2017 · External reference
Matching as nonparametric preprocessing for reducing model dependence in parametric causal inference.
10.1093/pan/mpl013 · 2007 · External reference
Matching methods for causal inference: a review and a look forward.
10.1214/09-sts313 · 2010 · External reference
The predictive value of age, creatinine, ejection fraction score for in-hospital mortality in patients with cardiogenic shock.
10.1097/mca.0000000000000776 · 2019 · External reference
Predictors of in-hospital mortality in patients with ST-segment elevation myocardial infarction complicated with cardiogenic shock.
10.1016/j.hlc.2017.10.023 · 2019 · External reference
Clinical characteristics and outcomes of acute coronary syndrome patients with intra-aortic balloon pump inserted in intensive cardiac care unit of a tertiary clinic.
2018 · External reference
Prognostic value of intermountain risk score for short- and long-term mortality in patients with cardiogenic shock.
10.1097/mca.0000000000001219 · 2023 · External reference
Cardiogenic shock after acute myocardial infarction: a review.
10.1001/jama.2021.18323 · ExternalCitation · doi-reference
Clinical profile, short and long-term outcomes of non-ischaemic cardiogenic shock: a FRENSHOCK sub-analysis.
10.1002/ehf2.15046 · ExternalCitation · doi-reference
Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples.
10.1002/sim.3697 · ExternalCitation · doi-reference
Management of cardiogenic shock: state-of-the-art.
10.1007/s00134-024-07618-x · ExternalCitation · doi-reference
Predictors of in-hospital mortality in patients with ST-segment elevation myocardial infarction complicated with cardiogenic shock.
10.1016/j.hlc.2017.10.023 · ExternalCitation · doi-reference
Statin therapy reduces the risk of ventricular arrhythmias, sudden cardiac death, and mortality in heart failure patients: a nationwide population-based cohort study.
10.1016/j.ijcard.2013.07.036 · ExternalCitation · doi-reference
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.
10.1016/j.jclinepi.2007.11.008 · ExternalCitation · doi-reference
The lipid and non-lipid effects of statins.
10.1016/s0163-7258(03)00055-x · ExternalCitation · doi-reference
MIMIC-IV, a freely accessible electronic health record dataset.
10.1038/s41597-022-01899-x · ExternalCitation · doi-reference
Immortal time bias in pharmaco-epidemiology.
10.1093/aje/kwm324 · ExternalCitation · doi-reference
Effect of statins on ventricular tachyarrhythmia, cardiac arrest, and sudden cardiac death: a meta-analysis of published and unpublished evidence from randomized trials.
10.1093/eurheartj/ehs005 · ExternalCitation · doi-reference
Management of cardiogenic shock complicating myocardial infarction: an update 2019.
10.1093/eurheartj/ehz363 · ExternalCitation · doi-reference
Matching as nonparametric preprocessing for reducing model dependence in parametric causal inference.
10.1093/pan/mpl013 · ExternalCitation · doi-reference
The predictive value of age, creatinine, ejection fraction score for in-hospital mortality in patients with cardiogenic shock.
10.1097/mca.0000000000000776 · ExternalCitation · doi-reference
Prognostic value of intermountain risk score for short- and long-term mortality in patients with cardiogenic shock.
10.1097/mca.0000000000001219 · ExternalCitation · doi-reference
Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes.
10.1136/bmj.b5087 · ExternalCitation · doi-reference
Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association.
10.1161/cir.0000000000000525 · ExternalCitation · doi-reference
Landmark analysis at the 25-year landmark point.
10.1161/circoutcomes.110.957951 · ExternalCitation · doi-reference
Double-adjustment in propensity score matching analysis: choosing a threshold for considering residual imbalance.
10.1186/s12874-017-0338-0 · ExternalCitation · doi-reference
Management of cardiogenic shock: a narrative review.
10.1186/s13613-024-01260-y · ExternalCitation · doi-reference
Matching methods for causal inference: a review and a look forward.
10.1214/09-sts313 · ExternalCitation · doi-reference
The role of inflammation in the pathogenesis of cardiogenic shock secondary to acute myocardial infarction: a narrative review.
10.3390/biomedicines12092073 · ExternalCitation · doi-reference
Patient characteristics, treatment and outcome in non-ischemic vs. ischemic cardiogenic shock.
10.3390/jcm9040931 · ExternalCitation · doi-reference
Favourable effect of statin therapy on early survival benefit at the time of percutaneous coronary intervention for ST-elevation myocardial infarction and shock.
10.4244/eijv6i3a58 · ExternalCitation · doi-reference
